Compare Champion Pacific Indonesia Tbk. (IGAR) vs RDI Insight ETF FTSE Indonesia Low Volatility Factor Index (XILV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Champion Pacific Indonesia Tbk. vs RDI Insight ETF FTSE Indonesia Low Volatility Factor Index — how do they compare? Champion Pacific Indonesia Tbk. trades at Rp414 (market cap 384.1B, 16.2K 24h volume), while RDI Insight ETF FTSE Indonesia Low Volatility Factor Index trades at Rp118 (market cap 2.74B, 41.4K 24h volume). The key difference: Champion Pacific Indonesia Tbk. is far larger — about 140.2× RDI Insight ETF FTSE Indonesia Low Volatility Factor Index's market cap, and RDI Insight ETF FTSE Indonesia Low Volatility Factor Index is more actively traded (41.4K versus 16.2K). Which is the better fit depends on your goals.
| IGAR | XILV | |
|---|---|---|
Market Cap | 384.1B | 2.74B |
Volume | 16.2K | 41.4K |
Lot | 162 | 414 |
Turnover | 6.65M | 4.9M |
Average Price | 410.64 | 118.3 |
Value | 6.65M | 4.9M |
Indicative Equilibrium Price | 414 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Champion Pacific Indonesia Tbk.
PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.
Read more on IGAR →
